Abstract
Neuralgia is defined as pain in the distribution of a specific nerve(s). Cranial neuralgias are characterized by craniofacial pain of varying character and distribution and are usually associated with, at least, some neurologic symptoms/deficits. Trigeminal neuralgia is the most common and the most severe of all cranial neuralgias and is characterized by recurrent attacks of pain in the distribution of one or more divisions of the trigeminal nerve. Glossopharyngeal neuralgia is defined as recurrent paroxysms of pain in the distribution of the auricular and pharyngeal branches of the vagus nerve as well as branches of the glossopharyngeal nerve and can rarely be associated with vagal symptoms, particularly syncope and/or bradycardia. Nervus intermedius neuralgia is characterized by brief paroxysms of unilateral pain in the auditory canal which can sometimes radiate to the parieto-occipital region. Occipital neuralgia is characterized by paroxysmal stabbing pain in the distribution of the greater, lesser, and/or third occipital nerves. Optic neuritis is an acute demyelinating condition characterized by retro-orbital pain with associated impairment of central vision. Headache attributed to ischemic ocular nerve palsy is characterized by unilateral frontal and/or periorbital pain caused by ischemic paresis of the ipsilateral third, fourth, or sixth cranial nerves. Recurrent painful ophthalmoplegic neuropathy is characterized by recurrent attacks of paresis of one or more ocular cranial nerves, with associated ipsilateral headache. Tolosa-Hunt syndrome consists of unilateral orbital pain associated with ophthalmoplegia and is caused by a granulomatous inflammation in the cavernous sinus, superior orbital fissure, or orbit. Paratrigeminal oculosympathetic syndrome is characterized by constant, unilateral pain in the distribution of the ophthalmic division of the trigeminal nerve, along with ipsilateral Horner’s syndrome, and is commonly caused by lesions involving the middle cranial fossa or the carotid artery. Burning mouth syndrome consists of recurrent intraoral burning sensation without clinically evident causative lesions. Persistent idiopathic facial pain is defined as persistent and recurrent facial and/or oral pain in the absence of clinical neurological deficit. Central neuropathic pain is a craniocervical pain syndrome of variable presentation caused by a demyelinating lesion in the central nervous system or an ischemic or hemorrhagic stroke.
The aim of this chapter is to review the chronic facial pain syndromes and highlight the etiology, epidemiology, clinical and diagnostic criteria, and up-to-date and practice-based treatment options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Cruccu G, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87(2):220–8.
Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124(Pt 12):2347–60.
Maarbjerg S, et al. Trigeminal neuralgia–a prospective systematic study of clinical characteristics in 158 patients. Headache. 2014;54(10):1574–82.
van Hecke O, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–62.
Katusic S, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol. 1990;27(1):89–95.
Zhang J, et al. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2013;12:Cd004029.
Bowsher D. Trigeminal neuralgia: an anatomically oriented review. Clin Anat. 1997;10(6):409–15.
Sjaastad O, et al. Trigeminal neuralgia. Clinical manifestations of first division involvement. Headache. 1997;37(6):346–57.
Rasmussen P. Facial pain. III. A prospective study of the localization of facial pain in 1052 patients. Acta Neurochir. 1991;108(1–2):53–63.
Linskey ME, Jho HD, Jannetta PJ. Microvascular decompression for trigeminal neuralgia caused by vertebrobasilar compression. J Neurosurg. 1994;81(1):1–9.
Cheng TM, Cascino TL, Onofrio BM. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology. 1993;43(11):2298–302.
Ildan F, et al. Isolated trigeminal neuralgia secondary to distal anterior inferior cerebellar artery aneurysm. Neurosurg Rev. 1996;19(1):43–6.
Figueiredo PC, et al. Arteriovenous malformation in the cerebellopontine angle presenting as trigeminal neuralgia. Arq Neuropsiquiatr. 1989;47(1):61–71.
Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10
Haddad FS, Taha JM. An unusual cause for trigeminal neuralgia: contralateral meningioma of the posterior fossa. Neurosurgery. 1990;26(6):1033–8.
Mohanty A, et al. Experience with cerebellopontine angle epidermoids. Neurosurgery. 1997;40(1):24–9. discussion 29-30
Leclercq D, Thiebaut JB, Heran F. Trigeminal neuralgia. Diagn Interv Imaging. 2013;94(10):993–1001.
Lazar ML, Kirkpatrick JB. Trigeminal neuralgia and multiple sclerosis: demonstration of the plaque in an operative case. Neurosurgery. 1979;5(6):711–7.
Jensen TS, Rasmussen P, Reske-Nielsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand. 1982;65(3):182–9.
Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology. 1988;38(12):1830–4.
Coffey RJ, Fromm GH. Familial trigeminal neuralgia and Charcot-Marie-tooth neuropathy. Report of two families and review. Surg Neurol. 1991;35(1):49–53.
Chong VF. Trigeminal neuralgia in nasopharyngeal carcinoma. J Laryngol Otol. 1996;110(4):394–6.
Bornemann A, et al. Amyloidoma of the gasserian ganglion as a cause of symptomatic neuralgia of the trigeminal nerve: report of three cases. J Neurol. 1993;241(1):10–4.
Katsuno M, Teramoto A. Secondary trigeminal neuropathy and neuralgia resulting from pontine infarction. J Stroke Cerebrovasc Dis. 2010;19(3):251–2.
Saito N, et al. Intramedullary cavernous angioma with trigeminal neuralgia: a case report and review of the literature. Neurosurgery. 1989;25(1):97–101.
Nakamura K, Yamamoto T, Yamashita M. Small medullary infarction presenting as painful trigeminal sensory neuropathy. J Neurol Neurosurg Psychiatry. 1996;61(2):138.
Love S, Hilton DA, Coakham HB. Central demyelination of the Vth nerve root in trigeminal neuralgia associated with vascular compression. Brain Pathol. 1998;8(1):1–11. discussion 11-2
Hilton DA, et al. Pathological findings associated with trigeminal neuralgia caused by vascular compression. Neurosurgery. 1994;35(2):299–303. discussion 303
Braga FM, et al. Familial trigeminal neuralgia. Surg Neurol. 1986;26(4):405–8.
Dworkin RH, et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(1 Suppl 1):S37–44.
Benoliel R, et al. Peripheral painful traumatic trigeminal neuropathy: clinical features in 91 cases and proposal of novel diagnostic criteria. J Orofac Pain. 2012;26(1):49–58.
Lambru G, Matharu MS. SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder? Curr Opin Neurol. 2014;27(3):325–31.
Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29(3):265–7.
Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1966;15(2):129–36.
Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ. 2007;334(7586):201–5.
Gronseth G, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183–90.
Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9(1):54–7.
Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol. 1968;19(2):129–36.
Cruccu G, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013–28.
Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;3:Cd005451.
Beydoun A. Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders. Epilepsy Behav. 2002;3s(3):S18–s22.
Sun D, et al. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in Central China. J Huazhong Univ Sci Technolog Med Sci. 2014;34(1):146–50.
Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15(3):240–4.
Zakrzewska JM, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223–30.
Lunardi G, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48(6):1714–7.
Lechin F, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46(9):960–3.
Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain. 1993;53(3):265–71.
Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain. 1987;28(1):45–50.
Kondziolka D, et al. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. J Neurosurg. 1994;80(6):993–7.
Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18(1):22–7.
Guardiani E, et al. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type a. Laryngoscope. 2014;124(2):413–7.
Wu CJ, et al. Botulinum toxin type a for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443–50.
Barker FG 2nd, et al. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334(17):1077–83.
Flickinger JC, et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys. 2001;51(2):449–54.
Katusic S, et al. Incidence and clinical features of glossopharyngeal neuralgia, Rochester, Minnesota, 1945–1984. Neuroepidemiology. 1991;10(5–6):266–75.
Rushton JG, Stevens JC, Miller RH. Glossopharyngeal (vagoglossopharyngeal) neuralgia: a study of 217 cases. Arch Neurol. 1981;38(4):201–5.
Resnick DK, et al. Microvascular decompression for glossopharyngeal neuralgia. Neurosurgery. 1995;36(1):64–8. discussion 68-9
Elias J, et al. Glossopharyngeal neuralgia associated with cardiac syncope. Arq Bras Cardiol. 2002;78(5):510–9.
Patel A, et al. Microvascular decompression in the management of glossopharyngeal neuralgia: analysis of 217 cases. Neurosurgery. 2002;50(4):705–10. discussion 710-1
Smith JH, et al. Triggerless neuralgic otalgia: a case series and systematic literature review. Cephalalgia. 2013;33(11):914–23.
Lee HL, et al. Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head. Clin Neurol Neurosurg. 2017;152:90–4.
Pulec JL. Geniculate neuralgia: long-term results of surgical treatment. Ear Nose Throat J. 2002;81(1):30–3.
Rupa V, Saunders RL, Weider DJ. Geniculate neuralgia: the surgical management of primary otalgia. J Neurosurg. 1991;75(4):505–11.
Lovely TJ, Jannetta PJ. Surgical management of geniculate neuralgia. Am J Otol. 1997;18(4):512–7.
Tang IP, et al. Geniculate neuralgia: a systematic review. J Laryngol Otol. 2014;128(5):394–9.
Dougherty C. Occipital neuralgia. Curr Pain Headache Rep. 2014;18(5):411.
Anthony M. Headache and the greater occipital nerve. Clin Neurol Neurosurg. 1992;94(4):297–301.
Jasper JF, Hayek SM. Implanted occipital nerve stimulators. Pain Physician. 2008;11(2):187–200.
Rodriguez M, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45(2):244–50.
Percy AK, Nobrega FT, Kurland LT. Optic neuritis and multiple sclerosis. An epidemiologic study. Arch Ophthalmol. 1972;87(2):135–9.
Roed H, et al. Systemic T-cell activation in acute clinically isolated optic neuritis. J Neuroimmunol. 2005;162(1–2):165–72.
The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Optic neuritis study group. Arch Ophthalmol. 1991;109(12):1673–8.
Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273–80.
Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83–99.
Wilker SC, et al. Pain in ischemic ocular motor cranial nerve palsies. Br J Ophthalmol. 2009;93(12):1657–9.
Jacobson DM, McCanna TD, Layde PM. Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol. 1994;112(7):961–6.
Berlit P. Isolated and combined pareses of cranial nerves III, IV and VI. A retrospective study of 412 patients. J Neurol Sci. 1991;103(1):10–5.
Rush JA, Younge BR. Paralysis of cranial nerves III, IV, and VI. Cause and prognosis in 1,000 cases. Arch Ophthalmol. 1981;99(1):76–9.
Gelfand AA, et al. Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012;27(6):759–66.
Lance JW, Zagami AS. Ophthalmoplegic migraine: a recurrent demyelinating neuropathy? Cephalalgia. 2001;21(2):84–9.
McMillan HJ, et al. Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine? Can J Neurol Sci. 2007;34(3):349–55.
Cakirer S. MRI findings in Tolosa-hunt syndrome before and after systemic corticosteroid therapy. Eur J Radiol. 2003;45(2):83–90.
La Mantia L, et al. Tolosa-hunt syndrome: critical literature review based on IHS 2004 criteria. Cephalalgia. 2006;26(7):772–81.
Iaconetta G, et al. Tolosa-hunt syndrome extending in the cerebello-pontine angle. Cephalalgia. 2005;25(9):746–50.
Solomon S, Lustig JP. Benign Raeder's syndrome is probably a manifestation of carotid artery disease. Cephalalgia. 2001;21(1):1–11.
Ikeuchi T, et al. Progression of cluster headache to Raeder's syndrome with marked response to corticosteroid therapy: a case report. Rinsho Shinkeigaku. 2005;45(4):321–3.
Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28(8):350–4.
Patton LL, et al. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl):S39.e1–13.
Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. 2005;1:Cd002779.
Evans RW, Drage LA. Burning mouth syndrome. Headache. 2005;45(8):1079–81.
Sardella A, et al. An up-to-date view on persistent idiopathic facial pain. Minerva Stomatol. 2009;58(6):289–99.
Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci. 2005;26(Suppl 2):s65–7.
Nicholson BD. Evaluation and treatment of central pain syndromes. Neurology. 2004;62(5 Suppl 2):S30–6.
Kim JS. Pharmacological management of central post-stroke pain: a practical guide. CNS Drugs. 2014;28(9):787–97.
Kumar B, et al. Central poststroke pain: a review of pathophysiology and treatment. Anesth Analg. 2009;108(5):1645–57.
Nurmikko TJ, Gupta S, Maclver K. Multiple sclerosis-related central pain disorders. Curr Pain Headache Rep. 2010;14(3):189–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Farooq, S., Schloemer, F.C. (2019). Chronic Facial Pain and Other Chronic Neuralgias. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-91491-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91490-9
Online ISBN: 978-3-319-91491-6
eBook Packages: MedicineMedicine (R0)